Search results for " glaucoma"
showing 10 items of 94 documents
Vascular risk factors in glaucoma: The results of a national survey
2007
Background The role of vascular risk factors in glaucoma is still being debated. To assess the importance of vascular risk factors in patients with primary open-angle glaucoma (POAG), data from the medical history of 2,879 POAG patients and 973 age-matched controls were collected and analyzed. Methods Design: observational survey. Setting: 35 Italian academic centers. Study population: POAG patients and age-matched controls. In order to reduce bias consecutive patients were included. Observation procedures: data concerning vascular risk factors were collected for all patients with a detailed questionnaire. A complete ophthalmological examination with assessment of intraocular pressure (IOP)…
Brinzolamide/brimonidine fixed-dose combination bid as an adjunct to a prostaglandin analog for open-angle glaucoma/ocular hypertension.
2019
Purpose: To evaluate the additive intraocular pressure–lowering effect of twice-daily brinzolamide 1%/brimonidine 0.2% fixed-dose combination (BBFC) as an adjunct to a prostaglandin analog (PGA) in patients with open-angle glaucoma or ocular hypertension insufficiently controlled with PGA monotherapy. Methods: In this Phase 4, double-masked trial, patients aged ⩾18 years, with a mean intraocular pressure of ⩾19 and <32 mm Hg in at least one eye were randomized (1:1) to receive BBFC + PGA ( n = 96) or vehicle + PGA ( n = 92) for 6 weeks. The primary endpoint was the mean change in diurnal intraocular pressure from baseline (averaged over 09:00 and 11:00 h) at Week 6. Results: The mean diu…
Sicurezza ed Efficacia dell’inserto Ologen™ nella chirurgia del glaucoma: risultati preliminari di uno studio prospettico di fase II
2009
Topical glaucoma medications – Clinical implications for the ocular surface
2022
Glaucoma is a leading cause of irreversible blindness. The use of topical eye drops to reduce intraocular pressure remains the mainstay treatment. These eye drops frequently contain preservatives designed to ensure sterility of the compound. A growing number of clinical and experimental studies report the detrimental effects of not only these preservatives but also the active pharmaceutical compounds on the ocular surface, with resultant tear film instability and dry eye disease. Herein, we critically appraise the published literature exploring the effects of preservatives and pharmaceutical compounds on the ocular surface. publishedVersion
Relationship between peripapillary perfusion density, peripapillary flow index and traditional glaucoma measurements in open‐angle glaucoma and ocula…
2021
Macular capillary perfusion density and macular vessel density in open‐angle glaucoma and ocular hypertension: a quantitative study using optical coh…
2021
Postoperative Komplikationen nach Silikonölinstillation
1997
Die Verwendung von Silikonol beinhaltet verschiedene Komplikationen, die den Erfolg des vitreoretinalen Eingriffes oftmals reduzieren. In einer retrospektiven Studie analysierten wir den Krankheitsverlauf von insgesamt 511 Augen (503 Patienten) mit komplizierter NH-Amotio verschiedener Genese, bei denen eine Pars-plana-Vitrektomie mit Silikonoltamponade durchgefuhrt worden war, um Komplikationen nach Silikonoltamponade festzustellen. Bei den untersuchten Augen handelte es sich um 267 komplizierte PVR-Amotiones, 126 diabetische Traktionsamotiones, 74 Amotiones nach perforierender Bulbusverletzung, 27 Amotiones mit Riesenris und 17 Augen mit verschiedenen anderen Netzhauterkrankungen wie Endo…
Effetto ipotensivo della Palmitoiletanolamide nei pazienti con pressione oculare borderline
2013
Iniziare la terapia del glaucoma: perché, quando, come.
2009
Efficacy and safety of the pars plana clip in the Ahmed valve device inserted via the pars plana in patients with refractory glaucoma
2010
Manuel Diaz-Llopis1,2,3, David Salom1,3, Salvador Garc&iacute;a-Delpech1,2,3, Patricia Udaondo1,3, Jose Maria Millan3,5, J Fernando Arevalo61Department of Ophthalmology, La Fe University Hospital of Valencia, Valencia, Spain; 2Department of Ophthalmology of the Valencia University, Valencia, Spain; 3Biomedical Network Research Centre on Rare Diseases (CIBERER), Valencia, Spain; 4Catholic University San Vicente Martir, Valencia, Spain; 5Department of Genetics, La Fe University Hospital of Valencia, Valencia, Spain; 6Clinica Oftalmologica Centro Caracas, Retina and VItreous Service, Caracas, DC, VenezuelaPurpose: To evaluate the efficacy and safety of the pars plana clip (PPC) in the Ahme…